<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>14 adult patients between 16 and 50 years old with small non-cleaved cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>) were prospectively treated from 1982 to 1990 with the LMB protocols of the Société Française d'Oncologie Pédiatrique (SFOP) </plain></SENT>
<SENT sid="1" pm="."><plain>No HIV-positive patients were included </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients had <z:e sem="disease" ids="C0849867" disease_type="Disease or Syndrome" abbrv="">extensive disease</z:e> with bad prognosis factors, i.e. 10 patients had Murphy stage III and 4 had stage IV with bone marrow involvement </plain></SENT>
<SENT sid="3" pm="."><plain>The LMB protocols were characterised by high-dose fractionated <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, high-dose <z:chebi fb="0" ids="44185">methotrexate</z:chebi> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>-MTX), and <z:chebi fb="1" ids="16040">cytosine</z:chebi> <z:chebi fb="0" ids="22601">arabinoside</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>No local or central <z:mp ids='MP_0008912'>nervous</z:mp> system irradiation was used </plain></SENT>
<SENT sid="5" pm="."><plain>Treatment duration ranged from 5 (LMB 84) to 12 (LMB 81) months </plain></SENT>
<SENT sid="6" pm="."><plain>There were no therapy-related <z:hpo ids='HP_0011420'>deaths</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients achieved complete remission (CR) </plain></SENT>
<SENT sid="8" pm="."><plain>6 patients relapsed between 2 and 30 months following CR </plain></SENT>
<SENT sid="9" pm="."><plain>8 of the 14 patients (57%) are still alive and disease-free after treatment by LMB protocol alone </plain></SENT>
<SENT sid="10" pm="."><plain>2 patients were salvaged with bone marrow transplantation after relapse and a total of 10 out of 14 patients (71%) are disease-free at the time of this report </plain></SENT>
<SENT sid="11" pm="."><plain>Our results showed the high curability of advanced Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> using a paediatric protocol, even in adult patients </plain></SENT>
<SENT sid="12" pm="."><plain>The LMB protocol may be applied to adult patients but requires intensive care during the induction period </plain></SENT>
</text></document>